Сообщество Forex трейдеров

Пожалуйста, войдите или зарегистрируйтесь.

Расширенный поиск  

Новости:

SMF - Just Installed!

Автор Тема: rbwh Republican Leaders: Dems Aren t Reaching Out To Pass Health Reform Bill  (Прочитано 6 раз)

DennisereWat

  • Jr. Member
  • **
  • Сообщений: 83
    • Просмотр профиля

Arjk CQ HealthBeat Examines Bush Administration Plan To Improve Price Transparency; HealthGrades Offers Price Reports for a Fee
 First Generic Version Of EpiPen Injector Approved By FDA And Could Lower Cost Of DrugTeva gets approval from the Food and Drug Administration to sell its version of the epinephrine auto-injector, but hasn t yet revealed its pricing. Mylan, the manufacturer of the brand-name EpiPen, has faced public criticism and congressional investigations for raising the price of its lifesaving drug 450 percent since 2004.Stat:FDA Approved The First-Ever Generic Version Of EpiPen聽The Food and Drug Administration approved the first-ever generic version of EpiPen Thursday 鈥?a move the agency says could help lower costs for the drug, which can carry a price tag of more than $600. It isnt clear how much the new version, which will be sold by Teva, will cost. But it may be a lower-cost option for individuals with allergies, who need to keep this lifesaving medicine with them at all times. Right now, a two-pack of EpiPen, marketed by Mylan, currently lists for $608.61. Mylan also makes its own  authorized generic  version, which it sells f yeti website or $300 per pair.  Swetlitz, 8/16 The Wall Street Journal:FDA Approves Tevas Generic Version Of EpiPen InjectorThe product, whose brand-name version is manufactured by Mylan NV, touche hydrojug d off a furor two years ago over its price increases of 548% over about a decade. ... Mylan introduced its own half-priced generic version of the drug in 2016.  owala website  Burton, 8/16 NPR:FDA Approves New Generic Version Of The EpiPen For Allergic ReactionsThe FDA says the approval of t Vsek Blue Shield, California s Biggest Obamacare Insurer, Vows It   s Not  Running For The Hills
 Tuesday, Feb 21 2012New York Times Profiles UNAIDS Executive Director Michel SidibeThe聽New York Times profile nike sb dunk s UNAIDS Executive Director Michel Sidib茅, recounting some of his successes sin yeezy ce becoming the head of the agency; quoting several colleagues about their experiences working with him; and providing a brief history of his family life, which he says helped him develop his diplomatic skills.  With a combination of bonhomie and persistence, he has delivered difficult messages to African presidents very persuasively in his three years in office,  the newspaper writes, adding,  Thanks, in part, to Mr. Sidib茅 s intensive lobbying, S owala water bottle outh Africa and China are rapidly revising their approaches to the [AIDS] epidemic, and he hopes Russia and India soon will too.  The newspaper notes,  Globally, Mr. Sidib茅 says, he is trying to  be a voice for those without one    McNeil, 2/20 .This is part of the Morning Briefing, a summary of health policy coverage from major news organizations.Sign up for an email subscription.Recent Morning BriefingsToday, November 20Wednesday, November 19Tuesday, November 18Monday, November 17Friday, November 14Thursday, November 13MoreRSSWe want to hear from you: Contact UsMore From KFF Health NewsComplaints About Gaps in Medicare Advantage Networks Are Common. Federal Enforcement Is Rare.Waning Immunity and Falling Vaccination Rates Fuel Pertussis OutbreaksA Small Texas Think Tank Cultivated Covid Dissidents. Now Theyre Running US Health Policy.A Hidden Hea